S*Bio and A*Star to develop new compounds to treat cancer
08-Feb-2007
Promising compounds may be further developed by A*STAR's newly formed Experimental Therapeutics Centre (ETC) and S*BIO to advance these compounds towards clinical development.
Most read news
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
France Biotech presents the results of its "Life Science Panorama 2010" survey
Go to page
High-fat diet accelerated heart transplant rejection in mice - Hyperlipidemia, Caused by a High-Fat Diet, Aggressively Accelerates Organ Rejection
Go to page
Celltech Collaborates With University Of Durham And Oxford Instruments To Pioneer New Magnetotherapy Technology
Go to page
Macrogen to establish subsidiary for new drug development
Go to page